A Phase 2 Study Of SU011248 In The Treatment Of Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006803/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to test whether sunitinib (SU011248) has activity and is safe in
patients with renal cell carcinoma (RCC) who have failed prior therapy with bevacizumab
(Avastin) -based treatment.
提供机构：
Vivli
创建时间：
2021-04-02
